Abstract:Introduction and aim Oncological patients often require intensive care unit (ICU) admission during the diagnosis and treatment process. Accurate determination of indications is crucial to maintain a balance between patient benefits and potential harms and ensure rational utilization of ICU beds. In our ICU, we primarily care for oncological patients. Our aim is to collect data on solid organ tumor patients discharged from the ICU, with a focus on assessing their survival chances and the continuity of post-discharge treatment. Patients and methods Retrospective review was conducted on data from patients discharged from the ICU between 2021 and 2022. Data recorded included age, gender, admission APACHE score, reason for admission, cancer type, stage; history of surgery, chemotherapy, radiotherapy before and after admission; ICU stay duration, and best supportive care (BSC) decisions. Results A total of 692 patients were hospitalized in the ICU, with 201 of them having solid tumors. Among these patients, 70 (34.8%) were discharged from the ICU, 56 were included in the study due to missing data for 14 patients. Of the patients included, 39 (69.6%) were male and 17 (30.4%) were female. The most common tumor types were gastrointestinal system tumors in 19 (33.9%) patients, urinary tract tumors in 11 (19.6%) patients, and head and neck squamous cell carcinoma in 7 (12.5%) patients. The primary reasons for hospitalization were acute respiratory failure in 16 (28.6%) patients, sepsis in 14 (25.0%) patients, and acute renal failure in 7 (12.5%) patients. The treatments received by the patients after discharge are shown in Table 1. The mean hospitalization duration was 9 days for patients with APACHE scores ≤18 and 17 days for patients with APACHE scores >18. Conclusion The prognosis of these patients is often considered poor, especially in the presence of metastases. However, advancements in ICU facilities, surgical techniques, chemotherapy, and radiotherapy provide opportunities for improved outcomes(1). Among the 201 ICU-admitted patients, 34.8% were discharged. Of the 56 patients included in the study, 64.2% with metastasis and 25.7% without metastasis received some form of treatment. This finding highlights the cost-effectiveness of ICU treatment for these patients. In conclusion, we believe that patients with solid tumors admitted to the ICU, even those with metastases, have a chance for treatment and extended survival following discharge. References 1. Dumas, G., Pastores, S. M. & Munshi, L. Five new realities in critical care for patients with cancer. Intensive Care Med 49, 345–348 (2023)

Evaluation of the treatment and survival chances in patients with solid organ tumors after discharge from the oncology hospital intensive care unit

Short- and Medium-Term Survival of Critically Ill Patients with Solid Cancer Admitted to the Intensive Care Unit

Characteristics and outcomes of patients with solid tumors receiving chemotherapy in the intensive care unit

Characterisation and Outcomes of Patients with Solid Organ Malignancies Admitted to the Intensive Care Unit: Mortality and Impact on Functional Status and Oncological Treatment

The Effect of the Underlying Malignancy on Short- and Medium-Term Survival of Critically Ill Patients Admitted to the Intensive Care Unit : A Retrospective Analysis Based on Propensity Score Matching

Clinical Outcomes and Determinants of Survival in Patients with Hematologic Malignancies Admitted to Intensive Care Units with Critical Illness

Impact of critical illness on continuation of anticancer treatment and prognosis of patients with aggressive hematological malignancies

Intensive Care Unit Outcomes and Mortality in Elderly Oncology Patients

Characteristics, management, and outcomes of patients with lung cancer admitted to a tertiary care intensive care unit over more than 20 years

Oncology and intensive care doctors' perception of intensive care admission of cancer patients: A cross-sectional national survey

Critical care management and intensive care unit outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy

Prognostic and risk factor analysis of cancer patients after unplanned ICU admission: a real-world multicenter study

Factors associated with cancer treatment resumption after ICU stay in patients with solid tumors

Characteristics and Clinical Outcomes of Patients with Lung Cancer Requiring ICU Admission: a Retrospective Analysis Based on the MIMIC-III Database

Improved survival of cancer patients admitted to the ICU between 2002 and 2011 at a U.S. teaching hospital

Outcome of patients with solid malignancies considered for intensive care unit admission: a single-center prospective cohort study

Treatment of Lung Cancer Patients With Actionable Mutations in the Intensive Care Unit

Treatment patterns and survival outcomes of patients admitted to the intensive care unit due to immune‐related adverse events of immune checkpoint inhibitors

A retrospective observational study on outcome of post-hematopoietic stem cell transplant patients needing intensive care unit admission

Lactate level is an independent predictor of mortality in patients with hematologic malignancy receiving urgent chemotherapy in intensive care unit

Treatment and prognosis of the patients with hematological diseases after chemotherapy and hematopoietic stem cell transplantation in ICU